SCHEMBL8067904

SCHEMBL8067904

CC(C)(OC(=O)C12CC3CC(CC(C3)C1)C2)c1ccncc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 12/20 1.00
CYP19A1 P11511 11/20 1.00
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 2/20 0.45
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
XBP1 P17861 1/20 0.43
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8067896 0.84 CYP19A1 (1.00) CYP17A1CYP19A1KMT2AALDH1A1MEN1
SCHEMBL3290991 0.73 CYP19A1 (0.56) CYP17A1CYP19A1MAPTLMNA
SCHEMBL25382147 0.72 CYP19A1 (0.55) CYP17A1CYP19A1MAPTLMNA
SCHEMBL131064 0.72 CYP17A1 (0.55) CYP17A1CYP19A1KMT2AALDH1A1MEN1
SCHEMBL8898120 0.71 CYP17A1 (1.00) CYP17A1CYP19A1KMT2AALDH1A1L3MBTL1
SCHEMBL8898867 0.71 CYP17A1 (1.00) CYP17A1CYP19A1KMT2AALDH1A1L3MBTL1
SCHEMBL8898126 0.71 CYP17A1 (1.00) CYP17A1CYP19A1KMT2AALDH1A1L3MBTL1
SCHEMBL28320432 0.71 CYP19A1 (0.54) CYP17A1CYP19A1MAPTLMNA
SCHEMBL25382149 0.71 CYP19A1 (0.54) CYP17A1CYP19A1KMT2AALDH1A1MEN1
SCHEMBL8075850 0.71 CYP19A1 (1.00) CYP17A1CYP19A1KMT2AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5595995-A ANTICARCINOGENIC AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1997-01-21 US claimed
EP-0640072-B1 Derivatives of pyridine as hydroxylase and lyase inhibitors BTG INT LTD (GB) 2000-08-23 EP disclosed
US-5595995-A ANTICARCINOGENIC AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1997-01-21 US disclosed
EP-0640072-A1 SUBSTITUTED PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL USE BTG INTERNATIONAL LIMITED (GB) 1995-03-01 EP disclosed
WO-1993023375-A1 SUBSTITUTED PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL USE BRITISH TECHNOLOGY GROUP LIMITED (GB) 1993-11-25 WO disclosed